European Journal of Cancer, ISSN 0959-8049, 2010, Volume 46, Issue 13, pp. 2389 - 2398
Abstract Background Although international guidelines have standardised conditions for G-CSF administration, real practice seems to vary. Patients and methods...
Hematology, Oncology and Palliative Medicine | Guideline | Criteria | Granulocyte colony-stimulating factor | Decision making | COLONY-STIMULATING FACTOR | SINGLE-ADMINISTRATION PEGFILGRASTIM | RANDOMIZED-TRIAL | INDUCED FEBRILE NEUTROPENIA | ACUTE MYELOID-LEUKEMIA | HEMATOPOIETIC GROWTH-FACTORS | CONTROLLED PHASE-III | CELL LUNG-CANCER | POSITIVE BREAST-CANCER | ONCOLOGY | NON-HODGKINS-LYMPHOMA | Recombinant Proteins - therapeutic use | Attitude of Health Personnel | Prospective Studies | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Cancer Care Facilities - statistics & numerical data | Granulocyte Colony-Stimulating Factor - therapeutic use | Filgrastim | Neoplasms - drug therapy | Professional Practice - trends | Drug Prescriptions - statistics & numerical data | Female | Aged | Pharmacy Service, Hospital - statistics & numerical data | Practice Guidelines as Topic | Macrophage colony stimulating factor
Hematology, Oncology and Palliative Medicine | Guideline | Criteria | Granulocyte colony-stimulating factor | Decision making | COLONY-STIMULATING FACTOR | SINGLE-ADMINISTRATION PEGFILGRASTIM | RANDOMIZED-TRIAL | INDUCED FEBRILE NEUTROPENIA | ACUTE MYELOID-LEUKEMIA | HEMATOPOIETIC GROWTH-FACTORS | CONTROLLED PHASE-III | CELL LUNG-CANCER | POSITIVE BREAST-CANCER | ONCOLOGY | NON-HODGKINS-LYMPHOMA | Recombinant Proteins - therapeutic use | Attitude of Health Personnel | Prospective Studies | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Cancer Care Facilities - statistics & numerical data | Granulocyte Colony-Stimulating Factor - therapeutic use | Filgrastim | Neoplasms - drug therapy | Professional Practice - trends | Drug Prescriptions - statistics & numerical data | Female | Aged | Pharmacy Service, Hospital - statistics & numerical data | Practice Guidelines as Topic | Macrophage colony stimulating factor
Journal Article
Nature, ISSN 0028-0836, 2011, Volume 478, Issue 7367, pp. 103 - 109
Blood pressure is a heritable trait influenced by several biological pathways and responsive to environmental stimuli. Over one billion people worldwide have...
COMMON VARIANTS | POPULATION | CLONING | MULTIDISCIPLINARY SCIENCES | LOCI | HEALTH | HYPERTENSION | GENOME-WIDE ASSOCIATION | Prevention | Genetic aspects | Research | Single nucleotide polymorphisms | Cardiovascular diseases | Risk factors | Hypertension | Confidence intervals | Genealogy | Cardiovascular disease | Genetics | Genomes | Standard deviation | Independent sample | Life Sciences | Medical and Health Sciences | Medicin och hälsovetenskap
COMMON VARIANTS | POPULATION | CLONING | MULTIDISCIPLINARY SCIENCES | LOCI | HEALTH | HYPERTENSION | GENOME-WIDE ASSOCIATION | Prevention | Genetic aspects | Research | Single nucleotide polymorphisms | Cardiovascular diseases | Risk factors | Hypertension | Confidence intervals | Genealogy | Cardiovascular disease | Genetics | Genomes | Standard deviation | Independent sample | Life Sciences | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Nature genetics, ISSN 1061-4036, 2011, Volume 43, Issue 4, pp. 333 - U153
We performed a meta-analysis of 14 genome-wide association studies of coronary artery disease (CAD) comprising 22,233 individuals with CAD (cases) and 64,762...
HEART-DISEASE | DESIGN | POLYMORPHISMS | METAANALYSIS | MYOCARDIAL-INFARCTION | VARIANTS | CHOLESTEROL | GENETICS | GENETICS & HEREDITY | EXPRESSION | GENOME-WIDE ASSOCIATION | Genetic Predisposition to Disease | Genome-Wide Association Study | Coronary Artery Disease - etiology | Gene Frequency | Humans | Middle Aged | Risk Factors | Male | Case-Control Studies | Alleles | Coronary Artery Disease - genetics | Adult | Female | Aged | Polymorphism, Single Nucleotide | Genetic aspects | Disease susceptibility | Research | Single nucleotide polymorphisms | Coronary heart disease | Health aspects | Risk factors | Studies | Genomes | Gene expression | Chromosomes | Meta-analysis
HEART-DISEASE | DESIGN | POLYMORPHISMS | METAANALYSIS | MYOCARDIAL-INFARCTION | VARIANTS | CHOLESTEROL | GENETICS | GENETICS & HEREDITY | EXPRESSION | GENOME-WIDE ASSOCIATION | Genetic Predisposition to Disease | Genome-Wide Association Study | Coronary Artery Disease - etiology | Gene Frequency | Humans | Middle Aged | Risk Factors | Male | Case-Control Studies | Alleles | Coronary Artery Disease - genetics | Adult | Female | Aged | Polymorphism, Single Nucleotide | Genetic aspects | Disease susceptibility | Research | Single nucleotide polymorphisms | Coronary heart disease | Health aspects | Risk factors | Studies | Genomes | Gene expression | Chromosomes | Meta-analysis
Journal Article
1994, Reissue., ISBN 0195084802, viii, 206
Islamic ideas about women and their role in society spark considerable debate both in the Western world and in the Islamic world itself. Despite the popular...
Qurʼan | Women in Islam | Women in the Qurʼan | Women in the Qur'an | Islam | Biography | Women in the Qurʾan | Qurʾan | Role | Women | Doctrine | Islamic | Qur'an | Society | Women in the Qu'ran
Qurʼan | Women in Islam | Women in the Qurʼan | Women in the Qur'an | Islam | Biography | Women in the Qurʾan | Qurʾan | Role | Women | Doctrine | Islamic | Qur'an | Society | Women in the Qu'ran
Book
2007, Landmark law cases & American society, ISBN 9780700615353, xi, 276
Book
JAMA, ISSN 0098-7484, 01/2006, Volume 295, Issue 2, pp. 180 - 189
CONTEXT Atherothrombosis is the leading cause of cardiovascular morbidity and mortality around the globe. To date, no single international database has...
GLOBAL BURDEN | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | QUALITY | WAIST CIRCUMFERENCE | MYOCARDIAL-INFARCTION | OVERWEIGHT | ATHEROSCLEROSIS | BODY-MASS INDEX | ACUTE CORONARY SYNDROMES | BMI | Prevalence | Global Health | Humans | Middle Aged | Risk Factors | Cardiovascular Diseases - therapy | Male | Thrombosis - epidemiology | Atherosclerosis - epidemiology | Drug Utilization | Outpatients | Atherosclerosis - therapy | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Cardiovascular Diseases - epidemiology | Female | Registries | Aged | Platelet Aggregation Inhibitors - therapeutic use | Thrombosis - therapy | Care and treatment | Atheroembolism | Cardiovascular diseases | Risk factors | Blood vessels | Cardiovascular disease | Medical treatment
GLOBAL BURDEN | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | QUALITY | WAIST CIRCUMFERENCE | MYOCARDIAL-INFARCTION | OVERWEIGHT | ATHEROSCLEROSIS | BODY-MASS INDEX | ACUTE CORONARY SYNDROMES | BMI | Prevalence | Global Health | Humans | Middle Aged | Risk Factors | Cardiovascular Diseases - therapy | Male | Thrombosis - epidemiology | Atherosclerosis - epidemiology | Drug Utilization | Outpatients | Atherosclerosis - therapy | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Cardiovascular Diseases - epidemiology | Female | Registries | Aged | Platelet Aggregation Inhibitors - therapeutic use | Thrombosis - therapy | Care and treatment | Atheroembolism | Cardiovascular diseases | Risk factors | Blood vessels | Cardiovascular disease | Medical treatment
Journal Article
Anticancer Research, ISSN 0250-7005, 01/2013, Volume 33, Issue 1, pp. 301 - 308
Aim: To carry out a prospective, multicenter and observational study describing prophylactic strategies [cycle delay, dose-reduction, (G-CSF) prescription] to...
Chemotherapy-induced neutropenia | Secondary prophylaxis | Pegfilgrastim | G-CSF | Febrile neutropenia | MORTALITY | SURVIVAL | TRIALS | ADULT CANCER-PATIENTS | MANAGEMENT | secondary prophylaxis | GUIDELINES | febrile neutropenia | pegfilgrastim | ONCOLOGY | RELATIVE DOSE INTENSITY | PATIENTS RECEIVING CHEMOTHERAPY | Prospective Studies | Humans | Middle Aged | Secondary Prevention | Neoplasms - drug therapy | Neoplasms - complications | Antineoplastic Agents - adverse effects | Neutropenia - prevention & control | Adolescent | Aged, 80 and over | Adult | Aged | Neutropenia - chemically induced | Granulocyte Colony-Stimulating Factor - administration & dosage
Chemotherapy-induced neutropenia | Secondary prophylaxis | Pegfilgrastim | G-CSF | Febrile neutropenia | MORTALITY | SURVIVAL | TRIALS | ADULT CANCER-PATIENTS | MANAGEMENT | secondary prophylaxis | GUIDELINES | febrile neutropenia | pegfilgrastim | ONCOLOGY | RELATIVE DOSE INTENSITY | PATIENTS RECEIVING CHEMOTHERAPY | Prospective Studies | Humans | Middle Aged | Secondary Prevention | Neoplasms - drug therapy | Neoplasms - complications | Antineoplastic Agents - adverse effects | Neutropenia - prevention & control | Adolescent | Aged, 80 and over | Adult | Aged | Neutropenia - chemically induced | Granulocyte Colony-Stimulating Factor - administration & dosage
Journal Article
Annals of Oncology, ISSN 0923-7534, 09/2014, Volume 25, Issue suppl_4, pp. iv522 - iv523
Abstract Aim: For chemotherapy regimens with intermediate FN risk (10–20%), physicians should assess patient risk factors to determine whether overall risk is...
Journal Article
The Lancet, ISSN 0140-6736, 06/2019, Volume 393, Issue 10191, pp. 2591 - 2598
In 2013, the interim analysis of the Protocol for Herceptin as Adjuvant therapy with Reduced Exposure (PHARE) trial could not show that 6 months of adjuvant...
MEDICINE, GENERAL & INTERNAL | FOLLOW-UP | MEAN SURVIVAL-TIME | JOINT ANALYSIS | HERA | CHEMOTHERAPY | Antimitotic agents | Breast cancer | Product development | Antineoplastic agents | Analysis | Heart | Adenocarcinoma | Cancer therapies | Subgroups | Metastases | Data dictionaries | Ethics | Randomization | Motivation | Consent | Safety | Statistical analysis | Angina pectoris | Survival | ErbB-2 protein | Patients | Nodes | Studies | Chemotherapy | Breast | Ventricle | Trastuzumab | Ejection | Tumors
MEDICINE, GENERAL & INTERNAL | FOLLOW-UP | MEAN SURVIVAL-TIME | JOINT ANALYSIS | HERA | CHEMOTHERAPY | Antimitotic agents | Breast cancer | Product development | Antineoplastic agents | Analysis | Heart | Adenocarcinoma | Cancer therapies | Subgroups | Metastases | Data dictionaries | Ethics | Randomization | Motivation | Consent | Safety | Statistical analysis | Angina pectoris | Survival | ErbB-2 protein | Patients | Nodes | Studies | Chemotherapy | Breast | Ventricle | Trastuzumab | Ejection | Tumors
Journal Article
The Journal of Allergy and Clinical Immunology, ISSN 0091-6749, 02/2019, Volume 143, Issue 2, pp. AB236 - AB236
Journal Article
Anticancer Research, ISSN 0250-7005, 01/2013, Volume 33, Issue 1, pp. 301 - 307
Aim: To carry out a prospective, multicenter and observational study describing prophylactic strategies [cycle delay, dose-reduction, (G-CSF) prescription] to...
Chemotherapy | Granulocyte colony-stimulating factor | Prophylaxis | Data processing | Breast cancer | Solid tumors | Age | Metastases | Neutropenia
Chemotherapy | Granulocyte colony-stimulating factor | Prophylaxis | Data processing | Breast cancer | Solid tumors | Age | Metastases | Neutropenia
Journal Article
Diabetes, ISSN 0012-1797, 2011, Volume 60, Issue 10, pp. 2624 - 2634
Proinsulin is a precursor of mature insulin and C-peptide. Higher circulating proinsulin levels are associated with impaired β-cell function, raised glucose...
POPULATION | TCF7L2 | GLUCOSE-HOMEOSTASIS | OBESITY | METAANALYSIS | ENDOCRINOLOGY & METABOLISM | SUSCEPTIBILITY LOCI | RISK | CORONARY HEART-DISEASE | INSULIN SENSITIVITY | BETA-CELL FUNCTION | Proinsulin - blood | Diabetes Mellitus, Type 2 - genetics | Humans | Genotype | Male | Diabetes Mellitus, Type 2 - metabolism | Insulin - blood | Genetic Variation | Diabetes Mellitus, Type 2 - blood | Fasting - blood | Polymorphism, Single Nucleotide - genetics | Adult | Female | Genome, Human | Type 2 diabetes | Genetic susceptibility | Genetic variation | Physiological aspects | Genetic aspects | Research | Health aspects | Risk factors | Genetics | Medical and Health Sciences | Medicin och hälsovetenskap
POPULATION | TCF7L2 | GLUCOSE-HOMEOSTASIS | OBESITY | METAANALYSIS | ENDOCRINOLOGY & METABOLISM | SUSCEPTIBILITY LOCI | RISK | CORONARY HEART-DISEASE | INSULIN SENSITIVITY | BETA-CELL FUNCTION | Proinsulin - blood | Diabetes Mellitus, Type 2 - genetics | Humans | Genotype | Male | Diabetes Mellitus, Type 2 - metabolism | Insulin - blood | Genetic Variation | Diabetes Mellitus, Type 2 - blood | Fasting - blood | Polymorphism, Single Nucleotide - genetics | Adult | Female | Genome, Human | Type 2 diabetes | Genetic susceptibility | Genetic variation | Physiological aspects | Genetic aspects | Research | Health aspects | Risk factors | Genetics | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article